As consequence, an alteration of the amount of MBP epitopes (e.g. MBP111–119) presented on dendritic cells due to the LMP2 polymorphism might affect the repertoire of MBP-reactive CD8+ T cells and, thereby their eventual activation during the early phases of MS onset. Here, PSMB9 is linked to myeloid sarcoma.